Jane Street’s Journey Medical DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-27,700
Closed -$130K – 11832
2026
Q1
$130K Buy
+27,700
New +$215K ﹤0.01% 10484

Other funds holding DERM

Jane Street's DERM Position: Q3 2026 in Review

Jane Street reduced its Journey Medical (DERM) stake by 63% in Q3 2026, selling an estimated $1.4M and leaving 118,576 shares worth $811K. The position accounts for ﹤0.01% of the portfolio, ranked #6914.

Jane Street first reported a position in DERM in Q4 2023 and has held it in 5 quarters since. The position peaked at $2.27M in Q2 2026. 74 funds tracked by Wall St. Rank hold DERM as of Q3 2026.

  • Jane Street held 118,576 shares of Journey Medical worth $811K as of Q3 2026.
  • Jane Street sold 201,445 Journey Medical shares in Q3 2026, an estimated $1.4M.
  • Journey Medical made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #6914 holding.
  • Jane Street first reported a position in Journey Medical in Q4 2023 and has held it in 5 quarters since.
  • Jane Street's Journey Medical position peaked at $2.27M in Q2 2026.
  • 74 funds tracked by Wall St. Rank held Journey Medical as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.